with Alzheimer's disease 相關
廣告
搜尋結果
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 7 日前A Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that ...
A New Drug Could Slow Alzheimer's. But Can Patients Get It?
Bloomberg· 6 日前A New Drug Could Slow Alzheimer's. But Can Patients Get It? A new medicine from Eli ... ...
A successful Alzheimer's drug will help Eli Lilly join the $1 trillion club
CNBC· 6 日前Eli Lilly became the most valuable health-care company in the world on the back of its ...
Why Aging Parents With Memory Loss Must Stop Managing Money
Forbes· 5 日前A new study published in the New York Times demonstrates some startling findings about loss of ability to make money decisions ...
About 4% of US adults age 65 and older have a dementia diagnosis, survey finds
Reuters· 5 日前Some 4% of U.S. adults aged 65 and older say they have been diagnosed with dementia ...
InnovationRx: Tarsus Pharmaceuticals Takes Aim At Disease-Causing Bugs
Forbes· 6 日前Around 25 million Americans are affected by the eye disease Demodex blepharitis, which is ...
Opinion | An Alzheimer Drug Gets a Boost
The Wall Street Journal· 6 日前Lilly defied the skeptics to push ahead with donanemab. It paid off.
Making a plan to pay for long-term care: Insurance and other alternatives
CNBC· 6 日前Stacey Hachenberg, 58, and her partner, Sharon Fleming, 53, have been caring for their parents ...
... start-up Neuroelectrics uses electricity and a headcap to reduce seizures in patients with ...
CNBC· 4 日前High up in the hills of Barcelona, brain science start-up Neuroelectrics is developing ...
Evolution May Be Purposeful And It’s Freaking Scientists Out
Forbes· 4 日前“Where are all the genetic cures?” asks Denis Noble, a frustrated biophysicist, Royal Society ...